The migratory behaviour of GBM cells is known to be conditioned by a number of tissue- and glioma-derived cytokines and growth factors [26] and among these, CXCL12 modulates different aspects of glioma biology, including migration [7,8,25]. This evidence concerns the gene CXCL12 and central nervous system cancer.